Medicine & Healthcare

Medicine & Healthcare PR

Healthcare PR isn’t just about following tech and development trends. It’s about building trust and transparency with customers and stakeholders through thought leadership. Below you’ll find the latest topics, journalists, and articles to get you started.

Medicine & Healthcare PR Pitch Ideas

  • Surge in emergency palliative care highlights shift towards comprehensive patient support
    Pitch Now
  • AI integration in healthcare transitions from possibility to strategic implementation
    Pitch Now
  • Ensitrelvir reduces COVID-19 risk showcasing post-exposure prophylaxis potential
    Pitch Now
  • Digital health ventures receive funding fueling tech-driven healthcare innovation
    Pitch Now
  • Revolutionary androgen blood test offers noninvasive endometriosis diagnosis option
    Pitch Now
  • Scottish advancements mark progress in rare cancer and menopause treatments
    Pitch Now

Preston Insights

In recent developments within the Medicine & Healthcare sector, there has been a significant surge in the integration of palliative care within emergency departments, particularly for cancer patients. From 2016 to 2023, emergency department-initiated hospice and palliative care consultations increased by 388%, highlighting a trend towards integrating supportive care into emergency settings post-COVID-19 pandemic. This shift underscores the expanding role of emergency departments in providing comprehensive care for patients with serious illnesses. Additionally, there is a growing focus on the role of artificial intelligence in healthcare, with discussions shifting from whether to adopt AI to how best to utilize it for improving patient care. This reflects a broader trend of digital health ventures receiving substantial funding, indicating a robust interest in leveraging technology to enhance healthcare delivery.

Another notable trend is the advancement in diagnostic and treatment options for various conditions. For instance, a new androgen blood test shows promise in diagnosing endometriosis, potentially offering a noninvasive alternative to surgical confirmation. In Scotland, the acceptance of tebentafusp for uveal melanoma and a non-hormonal menopause drug marks progress in addressing rare and specific health conditions. Moreover, the use of ensitrelvir as a post-exposure prophylaxis for COVID-19 among household contacts has shown a significant reduction in infection risk, emphasizing the ongoing efforts to manage the pandemic. These developments highlight the continuous evolution of medical research and treatment strategies, aiming to improve patient outcomes and address unmet needs in healthcare.

Preston Insights are generated by our in-house AI models. Our models are designed by experts to analyze and summarize thousands of current articles from our database on the topic of this page. We've selected articles from top-tier, US publications, and top niche publications for each industry. The results are up-to-date and manually verified by PR experts.

Preston Insights are generated by our in-house AI models. Our models are designed by experts to analyze and summarize hundreds of current articles from our database on the topic of this page. We've selected articles by top-tier, US publications, and top niche publications for each industry. The results are up-to-date and manually verified by PR experts.